Corebridge Financial’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-111,227	Closed	-$12.3M	–	1762
2025 Q1	$12.3M	Sell	111,227 -4,472	-4%	-$495K	0.07%	256
2024 Q4	$15.8M	Sell	115,699 -4,872	-4%	-$665K	0.09%	194
2024 Q3	$13.9M	Sell	120,571 -7,933	-6%	-$914K	0.07%	245
2024 Q2	$17.7M	Buy	+128,504	New	+$17.7M	0.1%	160